Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling.
absorption
bioequivalence
biopharmaceutical characterization
formulation
gastroPlus modeling
in silico modeling
intestinal absorption
physiologically based pharmacokinetic (PBPK) modeling
special populations
Journal
Journal of pharmaceutical sciences
ISSN: 1520-6017
Titre abrégé: J Pharm Sci
Pays: United States
ID NLM: 2985195R
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
received:
24
08
2018
revised:
31
10
2018
accepted:
01
11
2018
pubmed:
16
11
2018
medline:
20
2
2020
entrez:
16
11
2018
Statut:
ppublish
Résumé
SPRYCEL
Identifiants
pubmed: 30439460
pii: S0022-3549(18)30706-8
doi: 10.1016/j.xphs.2018.11.005
pii:
doi:
Substances chimiques
Suspensions
0
Tablets
0
Dasatinib
RBZ1571X5H
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
741-749Informations de copyright
Copyright © 2019 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.